Cargando…

Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways

Tripartite motif (Trim) 8 is an E3 ubiquitin ligase, interacting with and ubiquitinating diverse substrates, and is closely involved in innate immunity. However, the function of Trim8 in hepatic ischaemia/reperfusion (I/R) injury remains largely unknown. The aim of this study is to explore the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Qiu, Tianyu, Wang, Jiangqiao, Zhou, Zhongbao, Chen, Xiaoxiong, Ma, Long, Zhang, Jilin, Zou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643225/
https://www.ncbi.nlm.nih.gov/pubmed/31360105
http://dx.doi.org/10.7150/ijbs.33323
_version_ 1783437096788164608
author Tao, Qiu
Tianyu, Wang
Jiangqiao, Zhou
Zhongbao, Chen
Xiaoxiong, Ma
Long, Zhang
Jilin, Zou
author_facet Tao, Qiu
Tianyu, Wang
Jiangqiao, Zhou
Zhongbao, Chen
Xiaoxiong, Ma
Long, Zhang
Jilin, Zou
author_sort Tao, Qiu
collection PubMed
description Tripartite motif (Trim) 8 is an E3 ubiquitin ligase, interacting with and ubiquitinating diverse substrates, and is closely involved in innate immunity. However, the function of Trim8 in hepatic ischaemia/reperfusion (I/R) injury remains largely unknown. The aim of this study is to explore the role of Trim8 in hepatic I/R injury. Trim8 gene knockout mice and primary hepatocytes were used to construct hepatic I/R models. The effect of Trim8 on hepatic I/R injury was analysed via pathological and molecular analyses. The results indicated that Trim8 was significantly upregulated in liver of mice subjected to hepatic I/R injury. Trim8 knockout relieved hepatocyte injury triggered by I/R. Silencing of Trim8 expression alleviated hepatic inflammation responses and inhibited apoptosis in vitro and in vivo. Mechanistically, our study suggests that Trim8 deficiency may elicit hepatic protective effects by inhibiting the activation of transforming growth factor β-activated kinase 1 (TAK1)-p38/JNK signalling pathways. TAK1 was required for Trim8 function in hepatic I/R injury as TAK1 activation abolished Trim8 function in vitro. In conclusion, our study demonstrates that Trim8 deficiency plays a protective role in hepatic I/R injury by inhibiting the activation of TAK1-dependent signalling pathways.
format Online
Article
Text
id pubmed-6643225
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-66432252019-07-29 Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways Tao, Qiu Tianyu, Wang Jiangqiao, Zhou Zhongbao, Chen Xiaoxiong, Ma Long, Zhang Jilin, Zou Int J Biol Sci Research Paper Tripartite motif (Trim) 8 is an E3 ubiquitin ligase, interacting with and ubiquitinating diverse substrates, and is closely involved in innate immunity. However, the function of Trim8 in hepatic ischaemia/reperfusion (I/R) injury remains largely unknown. The aim of this study is to explore the role of Trim8 in hepatic I/R injury. Trim8 gene knockout mice and primary hepatocytes were used to construct hepatic I/R models. The effect of Trim8 on hepatic I/R injury was analysed via pathological and molecular analyses. The results indicated that Trim8 was significantly upregulated in liver of mice subjected to hepatic I/R injury. Trim8 knockout relieved hepatocyte injury triggered by I/R. Silencing of Trim8 expression alleviated hepatic inflammation responses and inhibited apoptosis in vitro and in vivo. Mechanistically, our study suggests that Trim8 deficiency may elicit hepatic protective effects by inhibiting the activation of transforming growth factor β-activated kinase 1 (TAK1)-p38/JNK signalling pathways. TAK1 was required for Trim8 function in hepatic I/R injury as TAK1 activation abolished Trim8 function in vitro. In conclusion, our study demonstrates that Trim8 deficiency plays a protective role in hepatic I/R injury by inhibiting the activation of TAK1-dependent signalling pathways. Ivyspring International Publisher 2019-06-04 /pmc/articles/PMC6643225/ /pubmed/31360105 http://dx.doi.org/10.7150/ijbs.33323 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Tao, Qiu
Tianyu, Wang
Jiangqiao, Zhou
Zhongbao, Chen
Xiaoxiong, Ma
Long, Zhang
Jilin, Zou
Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways
title Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways
title_full Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways
title_fullStr Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways
title_full_unstemmed Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways
title_short Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways
title_sort tripartite motif 8 deficiency relieves hepatic ischaemia/reperfusion injury via tak1-dependent signalling pathways
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643225/
https://www.ncbi.nlm.nih.gov/pubmed/31360105
http://dx.doi.org/10.7150/ijbs.33323
work_keys_str_mv AT taoqiu tripartitemotif8deficiencyrelieveshepaticischaemiareperfusioninjuryviatak1dependentsignallingpathways
AT tianyuwang tripartitemotif8deficiencyrelieveshepaticischaemiareperfusioninjuryviatak1dependentsignallingpathways
AT jiangqiaozhou tripartitemotif8deficiencyrelieveshepaticischaemiareperfusioninjuryviatak1dependentsignallingpathways
AT zhongbaochen tripartitemotif8deficiencyrelieveshepaticischaemiareperfusioninjuryviatak1dependentsignallingpathways
AT xiaoxiongma tripartitemotif8deficiencyrelieveshepaticischaemiareperfusioninjuryviatak1dependentsignallingpathways
AT longzhang tripartitemotif8deficiencyrelieveshepaticischaemiareperfusioninjuryviatak1dependentsignallingpathways
AT jilinzou tripartitemotif8deficiencyrelieveshepaticischaemiareperfusioninjuryviatak1dependentsignallingpathways